Hepatitis E during Tocilizumab Therapy in a Patient with Rheumatoid Arthritis: Case Report and Literature Review.

作者: Hidekazu Ikeuchi , Kana Koinuma , Masao Nakasatomi , Toru Sakairi , Yoriaki Kaneko

DOI: 10.1155/2018/6873276

关键词:

摘要: Hepatitis E is an acute self-limiting disease caused by hepatitis virus (HEV). Recent reports show that HEV can induce chronic or be reactivated in immunocompromised hosts. We report a 63-year-old woman with rheumatoid arthritis (RA) who developed during treatment tocilizumab. Analysis of serially stocked serum samples confirmed was primary infection and not viral reactivation. Her liver function improved after discontinuing tocilizumab remained within the normal range without reactivation for >5 years restarting also reviewed published cases RA treatment.

参考文章(22)
Nobuaki Sugawara, Atsushi Yawata, Kazuaki Takahashi, Natsumi Abe, Masahiro Arai, 劇症E型肝炎:"Kitami/Abashiri strain"が検出された第3例目 Kanzo. ,vol. 50, pp. 473- 474 ,(2009) , 10.2957/KANZO.50.473
Detlev Schultze, Bernhard Mani, Günter Dollenmaier, Roland Sahli, Andrea Zbinden, Pierre Alexandre Krayenbühl, Acute Hepatitis E Virus infection with coincident reactivation of Epstein-Barr virus infection in an immunosuppressed patient with rheumatoid arthritis: a case report. BMC Infectious Diseases. ,vol. 15, pp. 474- 474 ,(2015) , 10.1186/S12879-015-1146-Y
Jurjen Versluis, Suzan D. Pas, Hendrik J. Agteresch, Robert A. de Man, Jolanda Maaskant, Marguerite E. I. Schipper, Albert D. M. E. Osterhaus, Jan J. Cornelissen, Annemiek A. van der Eijk, Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation Blood. ,vol. 122, pp. 1079- 1086 ,(2013) , 10.1182/BLOOD-2013-03-492363
CHRISTIAN H. ROUX, RODOLPHE ANTY, STEPHANIE PATOURAUX, LIANA EULLER-ZIEGLER, Hepatitis E: are rheumatic patients at risk? The Journal of Rheumatology. ,vol. 40, pp. 99- 99 ,(2013) , 10.3899/JRHEUM.120599
Marie Leroy, Guillaume Coiffier, Charlotte Pronier, Louise Triquet, Aleth Perdriger, Pascal Guggenbuhl, Macrophage activation syndrome with acute hepatitis E during tocilizumab treatment for rheumatoid arthritis Joint Bone Spine. ,vol. 82, pp. 278- 279 ,(2015) , 10.1016/J.JBSPIN.2015.01.018
Nassim Kamar, Janick Selves, Jean-Michel Mansuy, Leila Ouezzani, Jean-Marie Péron, Joëlle Guitard, Olivier Cointault, Laure Esposito, Florence Abravanel, Marie Danjoux, Dominique Durand, Jean-Pierre Vinel, Jacques Izopet, Lionel Rostaing, Hepatitis E virus and chronic hepatitis in organ-transplant recipients. The New England Journal of Medicine. ,vol. 358, pp. 811- 817 ,(2008) , 10.1056/NEJMOA0706992
Florence Abravanel, Jean-Michel Mansuy, Anne Huynh, Nassim Kamar, Laurent Alric, Jean-Marie Peron, Christian Récher, Jacques Izopet, Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation Journal of Clinical Virology. ,vol. 54, pp. 152- 155 ,(2012) , 10.1016/J.JCV.2012.02.015
Harry R. Dalton, Richard P. Bendall, Frances E. Keane, Richard S. Tedder, Samreen Ijaz, Persistent carriage of hepatitis E virus in patients with HIV infection. The New England Journal of Medicine. ,vol. 361, pp. 1025- 1027 ,(2009) , 10.1056/NEJMC0903778
Hélène Bauer, Cécile Luxembourger, Jacques-Eric Gottenberg, Sophie Fournier, Florence Abravanel, Alain Cantagrel, Emmanuel Chatelus, Pascal Claudepierre, Christophe Hudry, Jacques Izopet, Sylvie Fabre, Guillaume Lefevre, Laurent Marguerie, Antoine Martin, Laurent Messer, Anna Molto, Béatrice Pallot-Prades, Yves-Marie Pers, Anne-Marie Roque-Afonso, Christian Roux, Christelle Sordet, Martin Soubrier, Claire Veissier, Daniel Wendling, Jean-Marie Péron, Jean Sibilia, Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter study. Medicine. ,vol. 94, ,(2015) , 10.1097/MD.0000000000000675